189 related articles for article (PubMed ID: 8508612)
1. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance.
Davies MJ; Rayman G; Gray IP; Day JL; Hales CN
Diabet Med; 1993 May; 10(4):313-20. PubMed ID: 8508612
[TBL] [Abstract][Full Text] [Related]
2. Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type 2 diabetes mellitus.
Davies MJ; Metcalfe J; Gray IP; Day JL; Hales CN
Diabet Med; 1993 May; 10(4):305-12. PubMed ID: 8508611
[TBL] [Abstract][Full Text] [Related]
3. Increased secretion of 32,33 split proinsulin after intravenous glucose in glucose-tolerant first-degree relatives of patients with non-insulin dependent diabetes of European, but not Asian, origin.
Gelding SV; Andres C; Niththyananthan R; Gray IP; Mather H; Johnston DG
Clin Endocrinol (Oxf); 1995 Mar; 42(3):255-64. PubMed ID: 7758230
[TBL] [Abstract][Full Text] [Related]
4. Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects.
Clark PM; Levy JC; Cox L; Burnett M; Turner RC; Hales CN
Diabetologia; 1992 May; 35(5):469-74. PubMed ID: 1521730
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
[TBL] [Abstract][Full Text] [Related]
6. Serum lipoprotein levels and plasma concentrations of insulin, intact and 32, 33 split proinsulin in normoglycaemic relatives of patients with type 2 diabetes.
Gelding SV; Andres C; Niththyananthan R; Richmond W; Gray IP; Johnston DG
Diabet Med; 1994 Oct; 11(8):748-54. PubMed ID: 7851068
[TBL] [Abstract][Full Text] [Related]
7. Excessive secretion of insulin precursors characterizes and predicts gestational diabetes.
Swinn RA; Wareham NJ; Gregory R; Curling V; Clark PM; Dalton KJ; Edwards OM; O'Rahilly S
Diabetes; 1995 Aug; 44(8):911-5. PubMed ID: 7621996
[TBL] [Abstract][Full Text] [Related]
8. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
[TBL] [Abstract][Full Text] [Related]
9. Are specific serum insulin levels low in impaired glucose tolerance and type II diabetes?: measurement with a radioimmunoassay blind to proinsulin, in the population of Wadena, Minnesota.
Goetz FC; French LR; Thomas W; Gingerich RL; Clements JP
Metabolism; 1995 Oct; 44(10):1371-6. PubMed ID: 7476300
[TBL] [Abstract][Full Text] [Related]
10. Hyperinsulinemia in nondiabetic Asian subjects using specific assays for insulin, intact proinsulin, and des-31, 32-proinsulin.
Nagi DK; Ali VM; Walji S; Jain SK; Yudkin JS
Diabetes Care; 1996 Jan; 19(1):39-42. PubMed ID: 8720531
[TBL] [Abstract][Full Text] [Related]
11. Follow-up of women with previous GDM. Insulin, C-peptide, and proinsulin responses to oral glucose load.
Persson B; Hanson U; Hartling SG; Binder C
Diabetes; 1991 Dec; 40 Suppl 2():136-41. PubMed ID: 1748243
[TBL] [Abstract][Full Text] [Related]
12. LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study.
Festa A; D'Agostino R; Mykkänen L; Tracy RP; Hales CN; Howard BV; Haffner SM
Diabetes Care; 1999 Oct; 22(10):1688-93. PubMed ID: 10526736
[TBL] [Abstract][Full Text] [Related]
13. True insulin and intact proinsulin levels in acromegalic patients.
Tavares EF; Dalbosco IS; Abucham J; Russo EM
Eur J Endocrinol; 1996 May; 134(5):549-53. PubMed ID: 8664973
[TBL] [Abstract][Full Text] [Related]
14. Intact proinsulin, des 31,32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes.
Nagi DK; Knowler WC; Mohamed-Ali V; Bennett PH; Yudkin JS
Diabetes Care; 1998 Jan; 21(1):127-33. PubMed ID: 9538983
[TBL] [Abstract][Full Text] [Related]
15. Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects--evidence against a modulating role for insulin.
Mohamed-Ali V; Gould MM; Gillies S; Goubet S; Yudkin JS; Haines AP
Diabetologia; 1995 Sep; 38(9):1110-6. PubMed ID: 8591827
[TBL] [Abstract][Full Text] [Related]
16. Hyperproinsulinaemia in patients with myotonic dystrophy.
Krentz AJ; Clark PM; Cox L; Williams AC; Nattrass M
Diabetologia; 1992 Dec; 35(12):1170-2. PubMed ID: 1478370
[TBL] [Abstract][Full Text] [Related]
17. Proinsulin, proinsulin intermediate and insulin in cystic fibrosis.
Hamdi I; Green M; Shneerson JM; Palmer CR; Hales CN
Clin Endocrinol (Oxf); 1993 Jul; 39(1):21-6. PubMed ID: 8348704
[TBL] [Abstract][Full Text] [Related]
18. Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance.
Larsson H; Ahrén B
J Clin Endocrinol Metab; 1999 Jun; 84(6):2068-74. PubMed ID: 10372712
[TBL] [Abstract][Full Text] [Related]
19. High plasma insulin and triglyceride concentrations and blood pressure in offspring of people with impaired glucose tolerance.
Zavaroni I; Mazza S; Luchetti L; Buonanno G; Bonati PA; Bergonzani M; Passeri M; Reaven GM
Diabet Med; 1990 Jul; 7(6):494-8. PubMed ID: 2142051
[TBL] [Abstract][Full Text] [Related]
20. Effect of sulphonylurea therapy on plasma insulin, intact and 32/33 split proinsulin in subjects with type 2 diabetes mellitus.
Davies MJ; Metcalfe J; Day JL; Grenfell A; Hales CN; Gray IP
Diabet Med; 1994 Apr; 11(3):293-8. PubMed ID: 8033529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
